Amgen

ASCO: Bristol Myers' KRAS confirmatory data avoid Amgen's flaws but leave FDA prospect unclear
Fierce Pharma
Sun, 06/2/24 - 02:51 pm
ASCO 2024
Bristol Myers Squibb
Amgen
KRAS inhibitors
Krazati
non-small cell lung cancer
FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters
Tue, 05/28/24 - 10:29 pm
Amgen
AstraZeneca
biosimilars
Soliris
Bkemv
Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD
Fierce Pharma
Mon, 05/20/24 - 11:25 am
Amgen
AstraZeneca
COPD
Sanofi
Regeneron
Tezspire
Dupixent
In Big Pharma's growth rankings, Lilly took top spot from Novo Nordisk in Q1
Fierce Pharma
Thu, 05/16/24 - 09:51 pm
Big Pharma
Eli Lilly
Novo Nordisk
earnings
Amgen
FDA approves Amgen drug for small cell lung cancer
Reuters
Thu, 05/16/24 - 09:47 pm
Amgen
tarlatamab
FDA
small cell lung cancer
Winners and Losers in Biopharma’s Q1 2024 Earnings Season
BioSpace
Wed, 05/15/24 - 11:30 am
earnings
Amgen
AstraZeneca
Novo Nordisk
Biogen
Bristol Myers Squibb
JNJ
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
Amgen's new Horizon products bolster top line despite continued Tepezza struggles
Fierce Pharma
Fri, 05/3/24 - 11:23 am
Amgen
Horizon Pharma
Krystexxa
Tepezza
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters
Thu, 05/2/24 - 10:19 pm
Amgen
clinical trials
obesity
AMG786
MariTide
Amgen’s profit slides, revenue jumps in Q1
Medical Marketing and Media
Thu, 05/2/24 - 10:09 pm
Amgen
earnings
Amgen Highlights New COPD, Asthma and Vasculitis Research at ATS 2024
BioSpace
Wed, 05/1/24 - 09:31 am
Amgen
Tezspire
COPD
AMG104
severe asthma
Tavneos
vasculitits
R&D
ATS
Amgen CEO nabs pay raise thanks to Horizon deal. Does that incentivize aggressive M&A?
Fierce Pharma
Thu, 04/18/24 - 10:21 pm
Amgen
Pharma CEOs
Bob Bradway
executive compensation
Amgen, facing potential Enbrel price cap in Colorado, takes state's new drug affordability board to court
Fierce Pharma
Tue, 03/26/24 - 04:31 pm
Amgen
Enbrel
Medicare
Colorado
drug pricing
Acelyrin adds proof-of-concept TED data to recent readout pile, cementing challenge to Amgen
Fierce Biotech
Wed, 03/20/24 - 11:50 am
Acellyrin
thyroid eye disease
clinical trials
lonigutamab
Amgen
Sandoz Nabs FDA Approvals for First Two Biosimilars for Amgen’s Denosumab
BioSpace
Wed, 03/6/24 - 11:29 am
Sandoz
biosimilars
FDA
Amgen
denosumab
Prolia
Jubbonti
Xgeva
Wyost
Amgen boots up Ohio 'smart facility' where it plans to hire 400
Fierce Pharma
Mon, 02/26/24 - 11:13 am
Amgen
Ohio
drug manufacturing
hirings
Amgen details rare disease ambitions following $28B Horizon acquisition
Medical Marketing and Media
Sun, 02/25/24 - 09:04 pm
Amgen
Horizon Therapeutics
rare disease
M&A
Colorado could cap payments for Amgen’s Enbrel
Stat
Thu, 02/22/24 - 11:47 am
Colorado
Amgen
autoimmune disease
Enbrel
reimbursement
Innovent's Tepezza rival one step closer to Chinese approval after phase 3 eye disease win
Fierce Biotech
Tue, 02/20/24 - 05:51 pm
Innovent Biologics
thyroid eye disease
Tepezza
China
Amgen
IBI311
Amgen makes progress with its Horizon prize Tepezza, but there's much work left to do
Fierce Pharma
Wed, 02/7/24 - 09:22 pm
Amgen
Horizon Therapeutics
M&A
Tepezza

Pages